Affiliations 

  • 1 Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
  • 2 Division of Nephrology and Hypertension, Department of Medicine, University of California-San Diego, San Diego, California, USA
  • 3 LIM 12, Division of Nephrology, University of São Paulo Medical School, São Paulo, Brazil
  • 4 Department of Medicine & Hemodialysis Unit, Sultanah Aminah Hospital, Johor Bahru, Malaysia
  • 5 Nephrology & Renal Transplant Medicine, Max Super Specialty Hospital, Saket, New Delhi, India
  • 6 Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
  • 7 Reknown Nephrology Associates, Hyderabad, India
Kidney Int Rep, 2017 Jul;2(4):519-529.
PMID: 28845471 DOI: 10.1016/j.ekir.2017.03.014

Abstract

The incidence of acute kidney injury (AKI) among acutely ill patients is reportedly very high and has vexing consequences on patient outcomes and health care systems. The risks and impact of AKI differ between developed and developing countries. Among developing countries, AKI occurs in young individuals with no or limited comorbidities, and is usually due to environmental causes, including infectious diseases. Although several risk factors have been identified for AKI in different settings, there is limited information on how risk assessment can be used at population and patient levels to improve care in patients with AKI, particularly in developing countries where significant health disparities may exist. The Acute Disease Quality Initiative consensus conference work group addressed the issue of identifying risk factors for AKI and provided recommendations for developing individualized risk stratification strategies to improve care. We proposed a 5-dimension, evidence-based categorization of AKI risk that allows clinicians and investigators to study, define, and implement individualized risk assessment tools for the region or country where they practice. These dimensions include environmental, socioeconomic and cultural factors, processes of care, exposures, and the inherent risks of AKI. We provide examples of these risks and describe approaches for risk assessments in the developing world. We anticipate that these recommendations will be useful for health care providers to plan and execute interventions to limit the impact of AKI on society and each individual patient. Using a modified Delphi process, this group reached consensus regarding several aspects of AKI risk stratification.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.